ECSP12011892A - COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY - Google Patents
COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPYInfo
- Publication number
- ECSP12011892A ECSP12011892A ECSP12011892A ECSP12011892A EC SP12011892 A ECSP12011892 A EC SP12011892A EC SP12011892 A ECSP12011892 A EC SP12011892A EC SP12011892 A ECSP12011892 A EC SP12011892A
- Authority
- EC
- Ecuador
- Prior art keywords
- therapy
- theobromine
- drugs
- combination
- opiate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un agente comprende teobromina y otro antitusivo que no es un opiato, para el uso simultáneo, secuencial o por separado en terapia. Preferentemente, la terapia es para la tos.An agent comprises theobromine and another antitussive that is not an opiate, for simultaneous, sequential or separate use in therapy. Preferably, the therapy is for cough.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0919893.8A GB0919893D0 (en) | 2009-11-13 | 2009-11-13 | Drug composition and its use in therapy |
PCT/GB2010/051896 WO2011058374A1 (en) | 2009-11-13 | 2010-11-12 | Drug combination with theobromine and its use in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP12011892A true ECSP12011892A (en) | 2012-09-28 |
Family
ID=41509327
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP12011893 ECSP12011893A (en) | 2009-11-13 | 2012-05-11 | COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY |
ECSP12011892 ECSP12011892A (en) | 2009-11-13 | 2012-05-11 | COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP12011893 ECSP12011893A (en) | 2009-11-13 | 2012-05-11 | COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2498776A1 (en) |
JP (2) | JP2013510842A (en) |
CN (1) | CN102740853B (en) |
AU (1) | AU2010317668C1 (en) |
BR (1) | BR112012011224A2 (en) |
CA (1) | CA2780704C (en) |
CO (1) | CO6551745A2 (en) |
EC (2) | ECSP12011893A (en) |
GB (1) | GB0919893D0 (en) |
IL (1) | IL219769A0 (en) |
MX (1) | MX2012005538A (en) |
NZ (1) | NZ599957A (en) |
PE (1) | PE20121472A1 (en) |
RU (1) | RU2587329C2 (en) |
SG (1) | SG10201407496SA (en) |
UA (1) | UA105940C2 (en) |
WO (1) | WO2011058374A1 (en) |
ZA (1) | ZA201204247B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3850568D1 (en) * | 1987-10-08 | 1994-08-11 | Andor Bilas | FABRIC MIXTURE TO STABILIZE THE METABOLISM LOCATION. |
EP0719156A1 (en) * | 1993-09-07 | 1996-07-03 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
HUP9700654A2 (en) * | 1997-03-26 | 1999-09-28 | Dezső Korbonits | Antitussive compositions containing theobromine |
US6608073B1 (en) * | 1998-10-14 | 2003-08-19 | New Millennium Pharmaceutical Research, Inc. | Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
HUP9802716A3 (en) * | 1998-11-25 | 2000-08-28 | Chinoin Gyogyszer Es Vegyeszet | Pharmaceutical composition of analgesic activity |
ES2528384T3 (en) * | 2001-12-12 | 2015-02-09 | The Government Of The United States Of America, As Represented By The Secretary Department Of Healt | Methods of using adenosine receptor inhibitors to enhance the immune response and inflammation |
WO2004075879A1 (en) * | 2003-02-28 | 2004-09-10 | Delex Therapeutics Inc. | Opioid delivery system |
CN1593451A (en) * | 2003-09-12 | 2005-03-16 | 杨喜鸿 | Externally applied medicine for promoting male erection |
JPWO2006064780A1 (en) * | 2004-12-14 | 2008-06-12 | 塩野義製薬株式会社 | Constipation treatment |
US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
KR20080009994A (en) * | 2006-07-25 | 2008-01-30 | 안국약품 주식회사 | Compositions for treating of cough |
-
2009
- 2009-11-13 GB GBGB0919893.8A patent/GB0919893D0/en not_active Ceased
-
2010
- 2010-11-12 WO PCT/GB2010/051896 patent/WO2011058374A1/en active Application Filing
- 2010-11-12 CN CN201080051628.4A patent/CN102740853B/en not_active Expired - Fee Related
- 2010-11-12 JP JP2012538416A patent/JP2013510842A/en active Pending
- 2010-11-12 SG SG10201407496SA patent/SG10201407496SA/en unknown
- 2010-11-12 RU RU2012124063/15A patent/RU2587329C2/en not_active IP Right Cessation
- 2010-11-12 BR BR112012011224A patent/BR112012011224A2/en not_active IP Right Cessation
- 2010-11-12 NZ NZ599957A patent/NZ599957A/en not_active IP Right Cessation
- 2010-11-12 AU AU2010317668A patent/AU2010317668C1/en not_active Ceased
- 2010-11-12 MX MX2012005538A patent/MX2012005538A/en unknown
- 2010-11-12 CA CA2780704A patent/CA2780704C/en not_active Expired - Fee Related
- 2010-11-12 EP EP10778715A patent/EP2498776A1/en not_active Ceased
- 2010-11-12 UA UAA201207163A patent/UA105940C2/en unknown
- 2010-11-12 PE PE2012000650A patent/PE20121472A1/en not_active Application Discontinuation
-
2012
- 2012-05-11 EC ECSP12011893 patent/ECSP12011893A/en unknown
- 2012-05-11 EC ECSP12011892 patent/ECSP12011892A/en unknown
- 2012-05-11 CO CO12078022A patent/CO6551745A2/en not_active Application Discontinuation
- 2012-05-13 IL IL219769A patent/IL219769A0/en unknown
- 2012-06-11 ZA ZA2012/04247A patent/ZA201204247B/en unknown
-
2015
- 2015-12-04 JP JP2015237086A patent/JP2016041748A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
IL219769A0 (en) | 2012-07-31 |
GB0919893D0 (en) | 2009-12-30 |
WO2011058374A1 (en) | 2011-05-19 |
CN102740853B (en) | 2015-04-08 |
SG10201407496SA (en) | 2015-02-27 |
ZA201204247B (en) | 2013-02-27 |
AU2010317668C1 (en) | 2016-02-11 |
CA2780704C (en) | 2018-07-17 |
JP2013510842A (en) | 2013-03-28 |
CO6551745A2 (en) | 2012-10-31 |
MX2012005538A (en) | 2012-09-28 |
ECSP12011893A (en) | 2012-10-30 |
JP2016041748A (en) | 2016-03-31 |
CA2780704A1 (en) | 2011-05-19 |
PE20121472A1 (en) | 2012-11-30 |
AU2010317668A1 (en) | 2012-06-07 |
AU2010317668B2 (en) | 2015-01-22 |
BR112012011224A2 (en) | 2017-03-01 |
EP2498776A1 (en) | 2012-09-19 |
NZ599957A (en) | 2014-05-30 |
CN102740853A (en) | 2012-10-17 |
RU2587329C2 (en) | 2016-06-20 |
RU2012124063A (en) | 2013-12-20 |
UA105940C2 (en) | 2014-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2014002406A1 (en) | Method for the treatment of refractory or resistant treatment depression comprising administering esketamine intravenously or intranasally alone or in combination with one or more antidepressants; pharmaceutical composition; and its use in the treatment of refractory or treatment resistant depression. | |
UY28933A1 (en) | COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | |
CL2011001811A1 (en) | A method of treating a patient who has suffered an acute myocardial infarction that comprises the use of an antifibrotic agent. | |
CO6551744A2 (en) | COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY | |
CL2011001232A1 (en) | Pharmaceutical combination comprising an antibody that specifically recognizes cd38 and at least cytarabine; and its use for cancer treatment | |
CL2007003523A1 (en) | COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE ACTIVITY OF PI3 QUINASA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE IN THE CANCER PROFILACTIC OR THERAPEUTIC TREATMENT | |
CL2008001268A1 (en) | Compounds derived from n- [6-amino-5-aryl-pyridin-2-yl] -carboxamide; pharmaceutical composition that includes them; combined pharmaceutical composition comprising them together with another additional pharmacological agent; and use them in the treatment of pain. | |
CL2012000702A1 (en) | Use of an alpha-7 nicotinic acetylcholine receptor agonist for the treatment of dyskinesia associated with dopamine agonist therapy in Parkinson's disease. | |
CL2007003520A1 (en) | COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE PI3 QUINASA ACTIVITY; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE FOR CANCER PROFILACTIC OR THERAPEUTIC TREATMENT. | |
DOP2012000290A (en) | 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH ANTI-TUMOR AGENTS FOR USE IN THE TREATMENT OF CANCER UTERO AND CANCER DE OVARIO | |
CL2008003902A1 (en) | Pharmaceutical formulation comprising tetrahydrocannabidivirine (thcv) and / or cannabidiol (cbd) together with aripiprazole or a metabolite thereof and its use in the prevention or treatment of psychosis or a psychotic disorder. | |
CL2012000772A1 (en) | Compounds derived from substituted carboxyamide heterocycles, ar antagonist; pharmaceutical composition comprising them; and use in the treatment of prostate cancer. | |
CL2012003026A1 (en) | Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity. | |
BR112012010027A2 (en) | device for personal use in a phototherapy | |
CL2007000311A1 (en) | Compounds derived from chromen-2-one; pharmaceutical composition that includes them; and their use in the treatment of a proliferative disorder such as cancer. | |
ECSP12011892A (en) | COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY | |
CL2011003327A1 (en) | Pharmaceutical composition comprising finafloxacin and an anti-inflammatory agent; use in the treatment of ophthalmic, otic or nasal infections. | |
CL2011002962A1 (en) | Use of at least one specific integrin ligand for the treatment of cancer, and where the drug is to be used in combination with at least one additional agent selected from a) one or more alkylating agents and b) one or more chemotherapeutic agents other than those previous. | |
CO6700840A2 (en) | Theobromine in combination with an expectorant or mucolytic for use in therapy | |
BR112012014159A2 (en) | THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE | |
CL2008003799A1 (en) | Pharmaceutical composition comprising raloxifene in immediate release tablet form; Useful for the treatment and / or prevention of osteoporosis. | |
CL2012003265A1 (en) | Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide. | |
AR070456A1 (en) | COMBINATION INCLUDING PACLITAXEL FOR THE TREATMENT OF CANCER OF OVARY AND ITS USE | |
UY29417A1 (en) | ENDOPARASITICID AGENTS | |
ECSP12012132A (en) | COMBINATION OF THEOBROMINE WITH A DESCONGESTIVE AND ITS USE FOR THE TOS TREATMENT |